Hjem › Brystkræft › Delaware
Brystkræft kliniske forsøg i Delaware
9 studier for Brystkræft søger deltagere på steder i Delaware.
Byer i Delaware
Officiel studietekst (engelsk)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Medical Oncology Hematology Consultants, Newark
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04585750A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Medical Oncology Hematology Consultants (MOHC) ( Site 8002), Newark
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07060807Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Medical Oncology Hematology Consultants, P.A., Newark
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT06982521Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Bayhealth Hospital Kent Campus, Dover
- Beebe Medical Center, Lewes
- Bayhealth Hospital Sussex Campus, Milford
- og 6 flere
RekruttererFase 3
Alder 18 til 60 · Kvinder · Opdateret 2. sep. 2026 · NCT05879926A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- Medical Oncology Hematology Consultants, PA, Newark
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 10. aug. 2026 · NCT06926868Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Beebe South Coastal Health Campus, Millville
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
- og 1 flere
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 17. mar. 2026 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Newark
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Bayhealth Hospital Kent Campus, Dover
- Beebe South Coastal Health Campus, Frankford
- Beebe Health Campus, Rehoboth Beach
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. okt. 2025 · NCT03418961MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- Medical Oncology and Hematology Consultants, Newark
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 20. aug. 2025 · NCT03053193Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.